Subscribe (free): , , , ,
Become a of TWiV!
Intro music is by .
Send your virology questions and comments to twiv@microbe.tv.
In his weekly clinical update, Dr. Griffin discusses high Influenza incidence and disease severity among children and adolescents aged <18 years, neurologic effects of SARS-CoV-2 transmitted among dogs, effectiveness of monovalent mRNA vaccines against Omicron XBB infection in Singaporean children younger than 5 years, the effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions, incidence and impact of acute pericarditis in hospitalized patients with 颁翱痴滨顿鈥19, serotonin reduction in post-acute sequelae of viral infection, prevalence and risk factors for long COVID and post-COVID-19 condition in Africa, safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with advanced chronic kidney disease and COVID-19, antiviral efficacy of molnupiravir vs ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19.
Links for this episode
- severity among children and adolescents aged <18 years (CDC) 5:00
- Neurologic effects of transmitted among dogs (EID) 10:24
- Effectiveness of mRNA vaccines against Omicron XBB infection in (JAMA) 17:11
- of COVID-19 vaccine in the prevention of post-COVID conditions (ASHE) 20:07
- Incidence and impact of acute pericarditis in hospitalized patients with (JAHA) 22:07
- in post-acute sequelae of viral infection (Cell) 28:09
- Prevalence and risk factors for in Africa (The Lancet) 33:00
- and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with kidney disease and COVID-19 (CID)
- Antiviral efficacy of molnupiravir vs ritonavir-boosted nirmatrelvir in patients with early
- Contribute to our 34:42
- on TWiV 1054 35:01
- Dr. Griffin’s COVID treatment summary ()
- Timestamps by . Thanks!